Callan Family Office’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$443K Buy
2,104
+23
+1% +$4.93K 0.01% 857
2026
Q1
$460K Sell
2,081
-1,239
-37% -$303K 0.01% 793
2025
Q4
$842K Buy
3,320
+1,655
+99% +$416K 0.02% 600
2025
Q3
$412K Sell
1,665
-171
-9% -$40.9K 0.01% 599
2025
Q2
$441K Buy
+1,836
New +$427K 0.01% 629

Other funds holding STE

Callan Family Office's STE Position: Q2 2026 in Review

Callan Family Office increased its Steris (STE) stake by 1.1% in Q2 2026, buying an estimated $4.93K and bringing the position to 2,104 shares worth $443K. The position accounts for 0.01% of the portfolio, ranked #857.

Callan Family Office first reported a position in STE in Q2 2025 and has held it in 5 quarters since. The position peaked at $842K in Q4 2025. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Callan Family Office held 2,104 shares of Steris worth $443K as of Q2 2026.
  • Callan Family Office bought 23 Steris shares in Q2 2026, an estimated $4.93K.
  • Steris made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #857 holding.
  • Callan Family Office first reported a position in Steris in Q2 2025 and has held it in 5 quarters since.
  • Callan Family Office's Steris position peaked at $842K in Q4 2025.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.